Speaking of a 'common lexicon' here's one in the biopharma space fresh off the press (I think): http://pharmaleaders.com/align-biopharma-announces-new-identity-management-s tandard-available-for-life-sciences-industry-input/ I haven't clicked through the non standard T&C's clickwrap around it however. Looks like they want to not be encumbered with restrictions on comments back? Looks like the word 'standard' may be more opinion than fact. Hard to tell. Catherine, inferring from the lifemedid.com domain, this sounds like an area your organization may circulate in . Thoughts on how it informs things in the idPro space and the approach to common vocabulary? C From: <dg-idpro-bounces@kantarainitiative.org> on behalf of Catherine Schulten <catherine.schulten@lifemedid.com> Date: Wednesday, April 12, 2017 at 10:04 AM To: "dg-idpro@kantarainitiative.org" <dg-idpro@kantarainitiative.org> Subject: [DG-IDPro] the need to develop a common vocabulary Found this relevant paragraph in some research I was doing. The following from a NIST workshop held in Jan 2016: Develop a common lexicon. Many participants identified a lack of standardized terminology regarding identity proofing processes and functions. For example, some attendees used the term ³verification² while others preferred ³validation² for the same process. For the purposes of NIST¹s work, attendees suggested a common vocabulary should be developed to help ensure consistency in the framework and across communities, and that the taxonomy be aligned to the best extent possible with existing schemes. http://csrc.nist.gov/publications/drafts/nistir-8103/nistir_8103_draft.pdf Catherine Schulten VP of Product Management - OrangeHook, Inc. / LifeMed ID 3009 Douglas Blvd., STE 200, Roseville, CA 95661 Direct: 954-290-1991 Website <http://www.orangehook.com/> | LinkedIn <https://www.linkedin.com/company-beta/4794831/> | Facebook <https://www.facebook.com/orangehook/?fref=ts> | Twitter <https://twitter.com/OrangeHookInc?lang=en> | YouTube <https://www.youtube.com/channel/UC1NXbg8WNI92qrCpmrea4CA> IMPORTANT NOTICE: This e-mail communication may contain confidential or legally privileged information and is intended to be received only by persons entitled to receive the confidential information it may contain. Please do not read, copy, forward or store this message unless you are an intended recipient of it. Any review, use, dissemination, distribution or copying of this communication by other than the intended recipient or that person's agent is strictly prohibited pursuant to the Electronic Communication Privacy Act,18 USCA 2510. If you have received this message in error, please notify the sender by forwarding it by email to the sender and then delete it completely from your computer system.